目的探讨面部肌张力障碍的临床治疗。
Objective To explore the clinical remedy of facial muscle dystonia.
目的：分析抗精神病药引起急性肌张力障碍的相关因素。
Objective:To study the risk factors associated with antipsychotics induced acute dystonia.
目的探讨立体定向核团毁损手术治疗局限性肌张力障碍的疗效。
Objective To analysis the outcome of stereotactic nucleus lesioning for focal dystonia patients.
遗传缺陷在某些病人中被认为是导致原发性肌张力障碍的原因。
Genetic defects are believed responsible for the primary dystonia in some patients.
我们正在了解肌张力障碍患者的大脑是如何处理感觉、运动信息。
We're looking to examine how sensory and motor information is handled in the brain in patients with dystonia.
笔者通过对来自5个家庭7例多巴反应性肌张力障碍患者的护理。
Objective To attach importance to the nursing of dopa- responsive dystonia. Methods 7 cases from 5 families were treated and nursed with Dopa- therapy.
结论多巴反应性肌张力障碍临床表现呈多样化，临床表现与年龄密切相关。
Conclusion the clinical manifestations of DRD are various and they are closely correlated with age.
继发性肌张力障碍，可以由脑部肿瘤、感染或者外界环境的特殊刺激等造成。
The secondary dystonia is caused by brain trauma, infection, or special stimulation of external environment, etc.
约30万人在北美患有肌张力障碍，一运动紊乱特点是进展性的运动控制障碍。
An estimated 300,000 people in North America are afflicted with dystonia, a disorder characterized by a progressive loss of motor control.
结论A型肉毒毒素局部注射是治疗头颈部肌张力障碍的一种安全、有效、简便的方法。
Conclusion BTXA local injection is a safe, effective, simple means for treating cranio-cervical dystonia.
方法回顾性分析10例多巴反应性肌张力障碍患者的临床表现、诊断方法和治疗效果。
Methods Systematic study of clinical features, diagnosis and therapeutic effect in 10 patients with DRD was performed and retrospectively analyzed.
结论A型肉毒毒素局部肌肉注射是治疗面部肌张力障碍的一种安全、有效、简便、易行的治疗方法。
Conclusions Botulinum toxin type a local injection is a safe, effective, simple and easy means for the treatment of facial muscle dystonia.
目的研究肉毒毒素a治疗颈部肌张力障碍的长期疗效，探讨继发性无应答现象的发生率及相关机制。
Objective to analyze the long term effect of botulinum toxin a (Btx-A) in cervical dystonia and to discuss the incidence and mechanisms of secondary non-responsiveness.
结论肌张力障碍是颅脑损伤后少见的并发症，但其临床经过特殊、治疗困难，向临床医生提出了挑战。
Conclusion Dystonia is a less common complication following TBI, but its pathogenesis and effective treatment give a challenge to clinicians.
FDA已经批准DBS用于治疗神经系统疾病，其中包括原发性震颤、帕金森症、肌张力障碍及重度强迫症。
The FDA has already approved DBS as a treatment for neurologic disorders, including essential tremor, Parkinson's disease, dystonia, and severe obsessive-compulsive disorder.
方法回顾性分析5例发作性运动诱发舞蹈手足徐动症（PKC）和2例发作性持续运动诱发肌张力障碍（PED）患者的临床资料。
Methods Retrospective analysis was performed in 5 patients suffering from paroxysmal kinesigenic choreoathetosis(PKC) and 2 patients with paroxysmal persistent exercise-induced dystonia(PED).
主要体征有意识障碍、四肢肌张力改变、肝脏大；
The signs included conscious disturbance, muscular tension low or high, liver enlarged.
主要体征有意识障碍、四肢肌张力改变、肝脏大；
The signs included conscious disturbance, muscular tension low or high, liver enlarged.
应用推荐